BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17068207)

  • 1. Imaging the alternative silencing of FGFR2 exon IIIb in vivo.
    Bonano VI; Oltean S; Brazas RM; Garcia-Blanco MA
    RNA; 2006 Dec; 12(12):2073-9. PubMed ID: 17068207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the intronic splicing silencers flanking FGFR2 exon IIIb.
    Wagner EJ; Baraniak AP; Sessions OM; Mauger D; Moskowitz E; Garcia-Blanco MA
    J Biol Chem; 2005 Apr; 280(14):14017-27. PubMed ID: 15684416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein.
    Carstens RP; Wagner EJ; Garcia-Blanco MA
    Mol Cell Biol; 2000 Oct; 20(19):7388-400. PubMed ID: 10982855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel intronic cis element, ISE/ISS-3, regulates rat fibroblast growth factor receptor 2 splicing through activation of an upstream exon and repression of a downstream exon containing a noncanonical branch point sequence.
    Hovhannisyan RH; Carstens RP
    Mol Cell Biol; 2005 Jan; 25(1):250-63. PubMed ID: 15601847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNAi-mediated PTB depletion leads to enhanced exon definition.
    Wagner EJ; Garcia-Blanco MA
    Mol Cell; 2002 Oct; 10(4):943-9. PubMed ID: 12419237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of sequences and mechanisms through which ISE/ISS-3 regulates FGFR2 splicing.
    Hovhannisyan RH; Warzecha CC; Carstens RP
    Nucleic Acids Res; 2006; 34(1):373-85. PubMed ID: 16410617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAZ elements alter transcription elongation and silencing of the fibroblast growth factor receptor 2 exon IIIb.
    Robson-Dixon ND; Garcia-Blanco MA
    J Biol Chem; 2004 Jul; 279(28):29075-84. PubMed ID: 15126509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of RNA-binding proteins that regulate FGFR2 splicing through the use of sensitive and specific dual color fluorescence minigene assays.
    Newman EA; Muh SJ; Hovhannisyan RH; Warzecha CC; Jones RB; McKeehan WL; Carstens RP
    RNA; 2006 Jun; 12(6):1129-41. PubMed ID: 16603716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suggestive evidence on the involvement of polypyrimidine-tract binding protein in regulating alternative splicing of MAP/microtubule affinity-regulating kinase 4 in glioma.
    Fontana L; Rovina D; Novielli C; Maffioli E; Tedeschi G; Magnani I; Larizza L
    Cancer Lett; 2015 Apr; 359(1):87-96. PubMed ID: 25578778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity.
    Oltean S; Sorg BS; Albrecht T; Bonano VI; Brazas RM; Dewhirst MW; Garcia-Blanco MA
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14116-21. PubMed ID: 16963563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypyrimidine tract-binding protein represses splicing of a fibroblast growth factor receptor-2 gene alternative exon through exon sequences.
    Le Guiner C; Plet A; Galiana D; Gesnel MC; Del Gatto-Konczak F; Breathnach R
    J Biol Chem; 2001 Nov; 276(47):43677-87. PubMed ID: 11557769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice.
    Baraniak AP; Chen JR; Garcia-Blanco MA
    Mol Cell Biol; 2006 Feb; 26(4):1209-22. PubMed ID: 16449636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence-based alternative splicing reporters for the study of epithelial plasticity in vivo.
    Somarelli JA; Schaeffer D; Bosma R; Bonano VI; Sohn JW; Kemeny G; Ettyreddy A; Garcia-Blanco MA
    RNA; 2013 Jan; 19(1):116-27. PubMed ID: 23185039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells.
    Zhu X; Lee K; Asa SL; Ezzat S
    Am J Pathol; 2007 May; 170(5):1618-28. PubMed ID: 17456767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A protocol for imaging alternative splicing regulation in vivo using fluorescence reporters in transgenic mice.
    Bonano VI; Oltean S; Garcia-Blanco MA
    Nat Protoc; 2007; 2(9):2166-81. PubMed ID: 17853873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypyrimidine tract-binding protein down-regulates fibroblast growth factor receptor 1 alpha-exon inclusion.
    Jin W; Bruno IG; Xie TX; Sanger LJ; Cote GJ
    Cancer Res; 2003 Oct; 63(19):6154-7. PubMed ID: 14559795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A stem structure in fibroblast growth factor receptor 2 transcripts mediates cell-type-specific splicing by approximating intronic control elements.
    Baraniak AP; Lasda EL; Wagner EJ; Garcia-Blanco MA
    Mol Cell Biol; 2003 Dec; 23(24):9327-37. PubMed ID: 14645542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTBP1 promotes the progression of hepatocellular carcinoma by enhancing the oncogenic splicing switch of FGFR2.
    Yu-Ying C; Qian Z; Meng-Hui G; Lan F; Peng-Bo C; Gang-Qiao Z
    Yi Chuan; 2024 Jan; 46(1):46-62. PubMed ID: 38230456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons.
    Boutz PL; Stoilov P; Li Q; Lin CH; Chawla G; Ostrow K; Shiue L; Ares M; Black DL
    Genes Dev; 2007 Jul; 21(13):1636-52. PubMed ID: 17606642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the mutually exclusive exons 8a and 8 in the CaV1.2 calcium channel transcript by polypyrimidine tract-binding protein.
    Tang ZZ; Sharma S; Zheng S; Chawla G; Nikolic J; Black DL
    J Biol Chem; 2011 Mar; 286(12):10007-16. PubMed ID: 21282112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.